Cargando…

Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma

Treatment of pancreatic ductal adenocarcinoma (PDAC) remains a clinical challenge. There is an urgent need to develop novel strategies to enhance survival and improve patient prognosis. MicroRNAs (miRNAs) play critical roles as oncogenes or tumor suppressors in the regulation of cancer development a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Shixiang, Fesler, Andrew, Huang, Wenjie, Wang, Yunchao, Yang, Jiali, Wang, Xianxing, Zheng, Yao, Hwang, Ga-Ram, Wang, Huaizhi, Ju, Jingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921186/ https://www.ncbi.nlm.nih.gov/pubmed/31846800 http://dx.doi.org/10.1016/j.omtn.2019.11.010

Ejemplares similares

Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma
por: Wang, Yunchao, et al.
Publicado: (2017)

microRNA based prognostic biomarkers in pancreatic Cancer
por: Guo, Shixiang, et al.
Publicado: (2018)

Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway
por: Chi, Bojing, et al.
Publicado: (2022)

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer
por: Hwang, Ga-Ram, et al.
Publicado: (2023)

TMPRSS4 Promotes Cell Proliferation and Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma by Activating ERK1/2 Signaling Pathway
por: Gu, Jianyou, et al.
Publicado: (2021)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR‐140‐5p/LMNB1 axis
por: Fu, Wen, et al.
Publicado: (2023)

Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL
por: Zhao, Zhiping, et al.
Publicado: (2020)

MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation
por: Huang, Wenjie, et al.
Publicado: (2020)

Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells
por: Wu, Ning, et al.
Publicado: (2017)

An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2014)

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake
por: Fesler, Andrew, et al.
Publicado: (2022)

Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma
por: Zhang, Junfeng, et al.
Publicado: (2020)

The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
por: Xie, Fuming, et al.
Publicado: (2023)

Microarray expression profile analysis of circular RNAs in pancreatic cancer
por: Guo, Shixiang, et al.
Publicado: (2018)

Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway
por: Xie, Fuming, et al.
Publicado: (2023)

Long-Term Effect of Pancreaticoduodenectomy Combined with Revascularization for Resectable Pancreatic Carcinoma in Elderly Patients
por: Yang, Jiali, et al.
Publicado: (2022)

Establishing and validating a pathway prognostic signature in pancreatic cancer based on miRNA and mRNA sets using GSVA
por: Zhang, Junfeng, et al.
Publicado: (2020)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
por: Fesler, Andrew, et al.
Publicado: (2017)

Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
por: Gu, Jianyou, et al.
Publicado: (2022)

Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
por: Zhang, Hui, et al.
Publicado: (2015)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

The emerging role of miR-506 in cancer
por: Li, Jian, et al.
Publicado: (2016)

Gα15 in early onset of pancreatic ductal adenocarcinoma
por: Innamorati, Giulio, et al.
Publicado: (2021)

Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
por: Jiang, Zhengting, et al.
Publicado: (2022)

Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
por: Zhu, Liang, et al.
Publicado: (2022)

miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer
por: Fesler, Andrew, et al.
Publicado: (2014)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma
por: Islam, Shajedul, et al.
Publicado: (2021)

Clinicopathological significance of MYL9 expression in pancreatic ductal adenocarcinoma
por: Matsushita, Katsunori, et al.
Publicado: (2021)

Duodenum-preserving pancreatic head resection compared to pancreaticoduodenectomy: A systematic review and network meta-analysis of surgical outcomes
por: Guo, Shixiang, et al.
Publicado: (2023)

Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients
por: Zhang, Rui, et al.
Publicado: (2014)

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
por: Du, Jiali, et al.
Publicado: (2020)

Development of microRNA-based therapy for pancreatic cancer
por: Fesler, Andrew, et al.
Publicado: (2019)

Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma
por: Ito, Zensho, et al.
Publicado: (2017)

Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance
por: Sha, Jianjun, et al.
Publicado: (2013)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
por: Yamada, Shinichiro, et al.
Publicado: (2021)

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation
por: Wu, Changping, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0rfgec8dp29mckrgqqq20e6v14